Vascular endothelial growth factor: molecular and biological aspects.
Ferrara
N
N
Department of Cardiovascular Research, Genentech, Inc., South San Francisco, CA 94080, USA.
D043925:Angiogenesis Inducing Agents / Q000627:therapeutic use; D000818:Animals; D001808:Blood Vessels / Q000187:drug effects; D003338:Corpus Luteum / Q000187:drug effects; D016228:Endothelial Growth Factors / Q000737:chemistry / Q000235:genetics / Q000502:physiology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008222:Lymphokines / Q000737:chemistry / Q000235:genetics / Q000502:physiology* / Q000627:therapeutic use; D051379:Mice; D018345:Mice, Knockout; D009389:Neovascularization, Pathologic / Q000209:etiology* / Q000628:therapy; D018919:Neovascularization, Physiologic; D011994:Recombinant Proteins / Q000627:therapeutic use; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D043925:Angiogenesis Inducing Agents; D016228:Endothelial Growth Factors; D008222:Lymphokines; D011994:Recombinant Proteins; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors